BOLT vs CLOV
Bolt Biotherapeutics (BOLT) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BOLT currently screens at market cap $11.3M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BOLT and CLOV stock pages for the full models.
Not investment advice.